-
Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients
Mar 10, 2025, 14:00 PM -
Perceived Health Status among Patients with Norovirus and Acute Gastroenteritis
Mar 10, 2025, 14:00 PM -
Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in France: A Pharmacoeconomic Model
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Serum Phosphate Levels and Hyperphosphatemia on Renal Outcomes: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Chemotherapy and Radiotherapy among Non-Small Cell Lung Cancer Patients with Brain Metastases: A SEER-based Cohort Analysis
Mar 10, 2025, 14:00 PM -
Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes
Mar 10, 2025, 14:00 PM -
Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations
Mar 10, 2025, 14:00 PM -
A Quantitative Exploration of Challenges to the Sustainability of the United States Biosimilar Market
Mar 10, 2025, 14:00 PM -
Cognitive Impairment at Initial Diagnosis of Alzheimer’s Disease: Patient Characteristics and Treatments in the Real-World Setting
Mar 10, 2025, 14:00 PM -
Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims
Mar 10, 2025, 14:00 PM -
Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study
Mar 10, 2025, 14:00 PM -
Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data
Mar 10, 2025, 14:00 PM -
No Claim Left Behind: Viability of Assessing Early Real-World Vaccine Effectiveness in Open and Closed Administrative Healthcare Claims
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Mar 10, 2025, 14:00 PM -
Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions
Mar 10, 2025, 14:00 PM -
Analyzing the Association Between Statin Use and New Onset Diabetes in the US: A Retrospective Analysis Using Integrated EHR and Claims Data
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Patients With Chronic Respiratory Disease: A Multicenter Randomized Controlled Trial
Mar 10, 2025, 14:00 PM